A cost-saving algorithm for rapid diagnosis of Staphylococcus aureus and susceptibility to oxacillin directly from positive blood culture bottles by combined testing with BinaxNOW® S. aureus and Xpert MRSA/SA assay

Diagnostic Microbiology and Infectious Disease

Volumn 78, Issue 4, 2014, Pages 352-355

  Yossepowitch, Orit ^a   Dan, Michael ^a,b   Kutchinsky, Anuta ^a   Gottesman, Tamar ^a   Schwartz Harari, Orna ^b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

BinaxNOW S. aureus Assay; Blood cultures; Staphylococcus aureus; X pert MRSA SA BC Assay

Indexed keywords

OXACILLIN;

ADULT; ALGORITHM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CONTROLLED STUDY; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; INTERMETHOD COMPARISON; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

BINAXNOW S. AUREUS ASSAY; BLOOD CULTURES; STAPHYLOCOCCUS AUREUS; X PERT MRSA/SA BC ASSAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BACTEREMIA; BLOOD; COST SAVINGS; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84895863953     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.01.001     Document Type: Article

References (19)

1. Alere BinaxNOW® Staphylococcus aureus Card (2009). http://www.accessdata.fda.gov/cdrh_docs/reviews/K090964.pdf.
2. Bauer K.A., West J.E., Balada-Llasat J.M., Pancholi P., Stevenson K.B., Goff D.A. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis 2010, 51:1074-1080.
3. Chang F.Y., Peacock J.E., Musher D.M., Triplett P., MacDonald B.B., Mylotte J.M., et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 2003, 82:333-339.
4. Dhiman N., Trienski T.L., Dipersio L.P., Dipersio J.R. Evaluation of the BinaxNOW(R) Staphylococcus aureus Test for rapid identification of gram-positive Cocci from VersaTREK(R) blood culture bottles. J Clin Microbiol 2013, 51:2939-2942.
5. Frye A.M., Baker C.A., Rustvold D.L., Heath K.A., Hunt J., Leggett E., Oethinger M. Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia. J Clin Microbiol 2012, 50:127-1233.
6. Clinical microbiology procedure handbook 2007, ASM Press, Washington,D.C. 2nd ed. L.S. Garcia, H.D. Isenberg (Eds.).
7. Hall K.K., Lyman J.A. Updated review of blood culture contamination. Clin Microbiol Rev 2006, 19:788-802.
8. Jukes L., Mikhail J., Bome-Mannathoko N., Hadfield S.J., Harris L.G., El-Bouri K., et al. Rapid differentiation of Staphylococcus aureus, Staphylococcus epidermidis and other coagulase negative staphylococci and meticillin susceptibility testing directly from growth-positive blood cultures by multiplex real-time PCR. J Med Microbiol 2010, 59:1456-1461.
9. Kim S.H., Kim K.H., Kim H.B., Kim N.J., Kim E.C., Oh M.D., Choe K.W. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2008, 52:192-197.
10. Lodise T.P., McKinnon P.S., Swiderski L., Rybak M.J. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003, 36:1418-1423.
11. Micek S.T. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2007, 45:S184-S190.
12. Nguyen D.T., Yeh E., Perry S., Luo R.F., Pinsky B.A., Lee B.P., et al. Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci. J Clin Microbiol 2010, 48:785-790.
13. Paul M., Kariv G., Goldberg E., Raskin M., Shaked H., Hazzan R., et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2010, 65:2658-2665.
14. Polisena J., Chen S., Cimon K., McGill S., Forward K., Gardam M. Clinical effectiveness of rapid tests for methicillin resistant Staphylococcus aureus (MRSA) in hospitalized patients: a systematic review. BMC Infect Dis 2011, 11:336-349.
15. Romero-Gómez M.P., Muñoz-Velez M., Gómez-Gil R., Mingorance J. Evaluation of combined use of MALDI-TOF and Xpert(®) MRSA/SA BC assay for the direct detection of methicillin resistance in Staphylococcus aureus from positive blood culture bottles. J Infect 2013, 67:91-92.
16. Ruimy R., Dos-Santos M., Raskine L., Bert F., Masson R., Elbaz S., et al. Accuracy and potential usefulness of triplex real-time PCR for improving antibiotic treatment of patients with blood cultures showing clustered Gram-positive cocci on direct smears. J Clin Microbiol 2008, 46:2045-2051.
17. Rupp M.E., Archer G.L. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis 1994, 19:231-243.
18. Weinstein M.P. Blood culture contamination: persisting problems and partial progress. J Clin Microbiol 2003, 41:2275-2278.
19. Wolk D.M., Struelens M.J., Pancholi P., Davis T., Della-Latta P., Fuller D., et al. Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J Clin Microbiol 2009, 47:823-826.